Cell and gene therapies (CGTs) represent the cutting edge of drug discovery. 1 These are amongst the most advanced medical treatments, specifically designed to correct the root genetic cause of an ...

CGTs present significant challenges across diagnosis, treatment, and post-treatment stages, requiring coordinated stakeholder efforts to streamline processes and reduce barriers. Early diagnosis and ...

Cell and gene therapies for degenerative eye diseases are still a long way off, but they have the potential to make a transformative difference to people’s lives. Vision impairment and loss caused by ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

Leaders from the world of cell and gene therapy, including molecular geneticists, immunotherapists, physicians, nonprofit directors, and patient advocates, shared their personal stories and policy ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular ...

Hospitals excel at designing services fit for their needs. A pediatric cancer center of excellence, for example, is likely to produce superior outcomes due to its robust, experienced, cross-functional ...

Forbes contributors publish independent expert analyses and insights. I'm a senior tech contributor who writes about science and technology Multiply Labs and Universal Robots have entered a ...

A Fayetteville teen is making history in North Carolina after undergoing a new gene therapy for sickle cell disease. Aaron Scott was diagnosed with sickle cell at birth. Other WRAL Top Stories Sickle ...

"Capricor stock soars after pivotal DMD cell therapy trial meets endpoints" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.